Radiation Oncology

Latest News

Novel Therapy Receives FDA RMAT Designation in Localized Prostate Cancer
Novel Therapy Receives FDA RMAT Designation in Localized Prostate Cancer

May 29th 2025

Full results from the phase 3 trial supporting CAN-2409 plus valacyclovir and radiation therapy in this indication will be presented at the 2025 ASCO Annual Meeting.

QOL/Continence Differences Remain Stable for TNT/CRT Groups in Rectal Cancer
QOL/Continence Differences Remain Stable for TNT/CRT Groups in Rectal Cancer

May 28th 2025

IMRT Does Not Improve Tolerability vs 3D-CRT in Advanced Rectal Cancer
IMRT Does Not Improve Tolerability vs 3D-CRT in Advanced Rectal Cancer

May 27th 2025

Among patients with rectal cancer who underwent total mesorectal excision following SCRT plus camrelizumab and chemotherapy, the 3-year OS rate was 93.3%.
Neoadjuvant SCRT Combo May Prolong Survival in Advanced Rectal Cancer

May 25th 2025

Navigating the Landscape of PSMA PET Imaging Agents in Prostate Cancer
Navigating the Landscape of PSMA PET Imaging Agents in Prostate Cancer

May 24th 2025

Video Series
Video Interviews
Podcasts
A dedicated, well-trained, and expert staff at the Ivy Brain Tumor Center enables the facility to be at the forefront of cutting-edge radiosurgery treatment.
Experts from Sibley Memorial Hospital discuss how multidisciplinary work has enhanced outcomes such as survival and resource use at their institution.
Uterine transposition, a surgical approach preserving fertility by moving the uterus out of the radiation field, may improve gynecologic cancer outcomes.
Experts from Vanderbilt Medical Center review mechanisms, supporting data, and patient cases associated with the use of IORT in pancreatic cancer.
AI tools may show utility in areas such as prostate diagnostic imaging, pathology, and treatment outcome predictions.
Terence T. Sio, MD, MS, highlights advances such as proton beam radiotherapy that may improve outcomes for those with non–small cell lung cancer.
Timothy Chen, MD, highlights how technologies such as ZAP-X and proton therapy may improve outcomes for patients with cancer.

More News